Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials
Better Metabolic Health Even at lower doses, GLP-1 can positively impact metabolic health by improving insulin sensitivity, reducing liver fat, and regulating appetite
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
The goal is not becoming smaller at any cost
doi: 10.1016/S0140-6736(21)00213-0 21 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al
Use dairy strategically, such as a sprinkle of feta on a salad rather than a cheese-heavy casserole